$1.39
0.00% today
Nasdaq, Feb 28, 05:14 pm CET
ISIN
US74039M1018
Symbol
POAI

Predictive Oncology Inc Stock price

$1.39
+0.00 0.00% 1M
+0.48 53.40% 6M
+0.57 69.51% YTD
-1.87 57.36% 1Y
-14.28 91.13% 3Y
-40.01 96.64% 5Y
-25,498.61 99.99% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.03 2.11%
ISIN
US74039M1018
Symbol
POAI
Sector

Key metrics

Market capitalization $10.02m
Enterprise Value $9.34m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.77
P/S ratio (TTM) P/S ratio 7.26
P/B ratio (TTM) P/B ratio 4.71
Revenue growth (TTM) Revenue growth -23.75%
Revenue (TTM) Revenue $1.38m
EBIT (operating result TTM) EBIT $-13.25m
Free Cash Flow (TTM) Free Cash Flow $-12.00m
Cash position $3.08m
EPS (TTM) EPS $-3.06
P/S forward 7.19
EV/Sales forward 6.70
Short interest 9.56%
Show more

Is Predictive Oncology Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Predictive Oncology Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Predictive Oncology Inc:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Predictive Oncology Inc:

Hold
100%

Financial data from Predictive Oncology Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1.38 1.38
24% 24%
100%
- Direct Costs 1.31 1.31
10% 10%
95%
0.07 0.07
80% 80%
5%
- Selling and Administrative Expenses 13 13
9% 9%
927%
- Research and Development Expense - -
-
-
-13 -13
9% 9%
-922%
- Depreciation and Amortization 0.52 0.52
43% 43%
38%
EBIT (Operating Income) EBIT -13 -13
11% 11%
-960%
Net Profit -14 -14
24% 24%
-1,012%

In millions USD.

Don't miss a Thing! We will send you all news about Predictive Oncology Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Predictive Oncology Inc Stock News

Neutral
GlobeNewsWire
9 days ago
PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), a leader in AI-driven drug discovery and biologics, today closed its previously announced registered direct offering for the purchase and sale of 363,336 shares of common stock at a purchase price of $1.50 per share priced at-the-market under Nasdaq rules.
Neutral
GlobeNewsWire
10 days ago
Company successfully identified several abandoned or discontinued drugs for further testing and development in ovarian and other cancer types
Neutral
Business Wire
16 days ago
SAN DIEGO--(BUSINESS WIRE)-- #CertisAI--Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application directed to Certis's predictive artificial intelligence/machine learning (AI/ML) platform, CertisAI™. “The patent marks an important milestone for our company,” said ...
More Predictive Oncology Inc News

Company Profile

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

Head office United States
CEO Raymond Vennare
Employees 34
Founded 2002
Website predictive-oncology.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today